Results
Consumers survey results of 2006 in category
Musculo-skeletal system / Medication for the treatment of diseases of the joints
Info The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.
 
II quarter (april—june)
 
III quarter (july—september)
 
IV quarter (october—december)
1.
~
Артрон (Unipharm, Inc) Favorite of Consumers – 2006 Link 24.05% 5
   
–. Індовазин  6.96% 4.86
 
2.
1
Терафлекс (Bayer)Link 20.89% 4.79
   
–. Гель живокосту Др.Тайсс  6.33% 4.55
 
3. Структум (Euromedex) 3.16% 1.45
  
–. Діклак гель  1.90% 1.36
 
4. Артростоп плюс  3.16% 1.25
  
–. ArthroStop+  1.27% 0.91
 
5. Артрофлекс  1.27% 0.46
  
–.
~
Зинаксин (Ferrosan)Link 0.63% 0.45
 
6. Дона  0.63% 0.33
 
View results of current, 2024 year

Normed consumer's score are calculated by 5-score scale, accordingly to the methodic of the research.
Notice
The competitor which has taken 1st place in this rating — is the best and the most successful Ukrainian medication of 2006 in the “Medication for the treatment of diseases of the joints” category!
Using this rating is only possible with obligatory link to the source.
This rating was built as a result of the study of social preferences in 2006, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.  Details…
Comments(36)
all in a row | positive | negative

No negative comments yet… Be the first to leave comment on this topic!

or
You may sign in using:
Enter with Facebook Enter with Google Enter with VK
Aye Nay
  

Achtung! Please be polite! Although that modertors of this web-portal are excessively democratic, any unethical, unqotable or just rude expressions, which abuse other visitors of this web site, can be deleted. Also will be deleted any spam and public comments with private phone numbers.